Home / Medications / Crestor

Crestor

Statin Drugs Linked to Effective Prostate Cancer Therapy


Submitted by Kyle Smith on September 21, 2010 – 12:39am

4.142855

Statin drug Rosuvastatin (brand name: Crestor), commonly prescribed for patients with high cholesterol, may prove effective in the treatment of prostate cancer, according to a new study led by Dr. Xiao-Yan Wen at St. Michael’s Hospital. The drug suppressed the growth of human prostate cancer cells implanted in mice, providing “solid pre-clinical evidence and a strong rationale for clinical trials of statins in the treatment of prostate cancer,” Wen said.

Vitamin B Niacin Offers No Additional Benefit to Statin Therapy


Submitted by Staff on November 18, 2009 – 7:00pm

5

The routine prescription of 1,500 mg of extended-release niacin daily with traditional cholesterol-lowering therapy offers no extra benefit in correcting narrowed arteries in seniors who already have coronary artery disease, a new study shows.

Ongoing Statin Therapy Associated With Lower Risk of Death


Submitted by Staff on February 10, 2009 – 4:00pm

0

Patients with high cholesterol levels who continually take statins appear to have a lower risk of death over four to five years, regardless of whether they already have diagnosed heart disease, according to a report in the February 9 issue of Archives of Internal Medicine.

Statin Therapy Ineffective in Breast Cancer Prevention


Submitted by Staff on February 5, 2009 – 4:00pm

2

Lab work in animals showed limited activity when statins were given to prevent breast cancer, according to a report in the February issue of Cancer Prevention Research.

Review Paper Helps Explain Statins’ Side Effects


Submitted by Staff on January 30, 2009 – 12:59am

0

A review paper, published in the online edition of American Journal of Cardiovascular Drugs, provides the most complete picture to date of reported side effects of statins, showing the state of evidence for each. The paper also helps explain why some people have a higher risk than others for such adverse effects.

Abbott Receives FDA Approval for Cholesterol Drug Trilipix


Submitted by Staff on December 17, 2008 – 2:22am

0

The U.S. Food and Drug Administration (FDA) has approved Abbott’s Trilipix (fenofibric acid) delayed-release capsules for use along with diet to help lower triglycerides and LDL (low-density lipoprotein, or “bad”) cholesterol and to raise HDL (hihg-density lipoprotein, or “good”) cholesterol in patients with lipid problems.

Breathing Easy Shouldn’t Be So Hard


Submitted by Staff on December 12, 2008 – 4:00pm

4

People who suffer from asthma have a lot of choices today for treating their condition. Unfortunately, these choices can lead to confusion–and preventable symptoms and attacks.

New Study Finds Statins Cut Heart Attack Risk in Women


Submitted by Staff on November 18, 2008 – 8:30am

0

For the first time ever, a new study provides direct evidence that cholesterol-lowering drugs called statins can prevent heart attacks, strokes and deaths among women.

Crestor May Nearly Halve Heart Attack, Stroke Risk for Certain People


Submitted by Staff on November 11, 2008 – 3:46am

0

New data from a study demonstrated that Crestor (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events, such as myocardial infarction (heart attack), stroke, arterial revascularization, hospitalization for unstable angina or death from CV causes by a dramatic 44 percent compared to placebo among men and women with elevated C-reactive protein levels but low to normal cholesterol levels.

Researcher Studies Ties Between Cholesterol Drugs, Muscle Problems


Submitted by Staff on November 6, 2008 – 3:00pm

0

A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.

Syndicate content